Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04215783 · ClinicalTrials.gov registry record
Childhood Allergy and the Neonatal Environment
A clinical trial of Asthma in Children and Allergy, sponsored by University of Wisconsin, Madison.
- Active
- Registry status
- 499
- Enrollment target
- 4
- Study locations
NCT04215783: Active study of Asthma in Children and Allergy, sponsored by University of Wisconsin, Madison.
NCT04215783 is a study of Asthma in Children and Allergy that is active but no longer recruiting, run by University of Wisconsin, Madison. The registered enrollment target is 499 participants, above the 194-participant average among 44 other Asthma in Children trials with a reported enrollment target (157% higher). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04215783, a study of Asthma in Children and Allergy, is active but no longer recruiting, sponsored by University of Wisconsin, Madison.
- ACTIVE NOT RECRUITING
- Registry status
- 499 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this research study is to study the relationship between childhood asthma, allergies, and early-life environmental factors that may cause childhood asthma and allergies. Previous birth cohort studies have found early-life environmental factors such as allergies, pollutants, viruses and bacteria have all contributed to the development of asthma and allergies. Investigators are doing this research because there continues to be a strong need to understand the root causes of asthma and allergies. The CANOE study is an observational cohort study, which means investigators are not asking participants or participant's child to change their medications and investigators will not be giving participants or participant's child a study drug.
Primary Outcome
Number of children with recurrent wheezing will be reported. Recurrent wheeze, defined as at least 2 episodes of wheeze with one occurring in the last 12 months of study participation for children between 2 and 3 years of age.
Conditions Studied
Study Locations (4)
Michigan
- Henry Ford Health Systems - Detroit
Missouri
- Washington University School of Medicine - St Louis
Tennessee
- Vanderbilt University Medical Center - Nashville
Wisconsin
- University of Wisconsin - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 499 participants |
| Start Date | 2020-03-04 |
| Est. Completion | 2027-08-31 |
What the registry record for NCT04215783 still lists
NCT04215783 is an observational study that tracks outcomes without assigning an intervention. The registered 499 participants enrollment target is mid-sized for trials with a published cap, above the 194-participant average among 44 other Asthma in Children trials with a reported enrollment target (157% higher).
The record links to 2 conditions, with Asthma in Children appearing as the primary indexed condition, and to 0 interventions.
NCT04215783 reports a single indexed study location in Michigan, Missouri, Tennessee.
Frequently Asked Questions
What is clinical trial NCT04215783 about?
NCT04215783 is a clinical study titled "Childhood Allergy and the Neonatal Environment". The purpose of this research study is to study the relationship between childhood asthma, allergies, and early-life environmental factors that may cause childhood asthma and allergies. Previous birth cohort studies have found early-life environmental factors such as allergies, pollutants, viruses an...
What is the current status of trial NCT04215783?
This trial is currently active not recruiting. The enrollment target is 499 participants. The study started on 2020-03-04. Estimated completion is 2027-08-31.
What conditions does trial NCT04215783 study?
This clinical trial studies the following conditions: Asthma in Children, Allergy.
Who is sponsoring clinical trial NCT04215783?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04215783 being conducted?
This trial has 4 study locations across Michigan, Missouri, Tennessee, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma in Children
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04215783's enrollment target sits among peer trials
499 7th of 44 higher than 38 of 44 other Asthma in Children trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma in Children trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Action Towards Health Equity and Improved Air Quality in the Duwamish Valley: A Multilevel Asthma Intervention
RECRUITING · NA
-
SMART Implementation-Effectiveness Trial 1
RECRUITING · NA
-
Mechanistic Study of Inspiratory Training in Childhood Asthma (MICA)
RECRUITING · NA
-
Wearable Electronic Breath Sound Sensing Device
RECRUITING
-
A Culturally Tailored Scalable Asthma Intervention for Hispanic Children (Asthma Guardian)
RECRUITING · NA
-
Impact of Sleep Duration on Immune Balance in Urban Children With Asthma
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04137900 · 499 participants · Phase 1
Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies
- NCT06733480 · 499 participants · NA
Innovating Physical Therapy: A Pilot Study on Band Connect's Impact on Compliance, Satisfaction, and Revenue
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI